CN1215857C - Medicine for treating cow mammitis - Google Patents

Medicine for treating cow mammitis Download PDF

Info

Publication number
CN1215857C
CN1215857C CN 02145905 CN02145905A CN1215857C CN 1215857 C CN1215857 C CN 1215857C CN 02145905 CN02145905 CN 02145905 CN 02145905 A CN02145905 A CN 02145905A CN 1215857 C CN1215857 C CN 1215857C
Authority
CN
China
Prior art keywords
medicine
present
mammitis
mastitis
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 02145905
Other languages
Chinese (zh)
Other versions
CN1491675A (en
Inventor
赵志敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02145905 priority Critical patent/CN1215857C/en
Publication of CN1491675A publication Critical patent/CN1491675A/en
Application granted granted Critical
Publication of CN1215857C publication Critical patent/CN1215857C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses veterinary medicine for treating bovine mastitis, which is characterized in that the present invention is a pure traditional Chinese medicine preparation prepared by compounding various kinds of traditional Chinese medicine in certain weight proportions. The present invention which has good medicine synergism can kill staphylococcus aureus and streptococcus hemolyticus leading to bovine mastitis and has the functions of heat elimination and pain relief for congestive inflammation.

Description

The medicine of treatment Mammitis of cattle
Technical field
The present invention relates to the veterinary and use medicine, a kind of specifically veterinary drug for the treatment of Mammitis of cattle.
Background technology
Along with the raising of living standards of the people, the market prospect of milk and milk products is boundless, and the situation that demand exceeds supply will take place, so current dairy has the great development space, yet pain in the neck is the mastitis of milch cow, especially latent mammitis, the seriously sound development of prestige association world's dairy.Milch cow lactation period sickness rate be generally 20-60%, the recessive type sickness rate is up to more than 70%, causes output to reduce, milk matter descends, and brings enormous economic loss to the dairy farmer.At present, though it is a lot of to treat the report of this disease, generally still adopt cephalo-type, neomycin or enrofloxacin or green grass or young crops, streptomycin coupling etc.Treatment recessive type mastitis, employing levamisole hydrochloride that has now and chitosan etc., but drug residue is big, and effect is not ideal.
Summary of the invention
Purpose of the present invention just provides the pure Chinese medicinal preparation medicine of a kind of good effect, short treating period, consumption is few, residual less, cost is low treatment Mammitis of cattle.Is the epoch at center now with back to nature with life sciences, and research directions that some developed countries propose from synthetics turn to the medicine of seeking treatment in natural Chinese medicinal herb.So we take active action,, develop prescription with pure Chinese medicine extraction effective ingredient again through clinical trial for many years, bulge test repeatedly shows according to available data: evident in efficacy, safely, have no side effect noresidue, do not influence milk matter, the melancholy of no commodity inspection is subjected to deeply that numerous dairy farmers are beautiful to be looked at.
The present invention be directed to Mammitis of cattle, mastitis many because of staphylococcus, haemolysis coccus institute extremely, choose and have good synergistic medicine and carry out the compatibility preparation.Radix Taraxaci contains multiple triterpene alcohol, and herb contains inositol, the Herba Taraxaci bitter principle, and it has extremely strong killing action to staphylococcus and haemolysis coccus.Mastitis is though mastitis are caused that by multiple factor staphylococcus and haemolysis coccus are wherein main chief culprits.So adopting Herba Taraxaci is monarch, Radix Isatidis, Fructus Forsythiae are ministerial drug, and auxilliary monarch drug strengthens the toxin expelling anti-inflammatory effect, and assistant makes Herba Violae, Radix Scutellariae be both heat-clearing and toxic substances removing, the good assistant of eliminating carbuncle eliminating stagnation, and the auxilliary the monarch and his subjects of common association wipe out focus.Cooperative cooperatings such as Herba Taraxaci and Radix Isatidis, Fructus Forsythiae, Radix Scutellariae, Herba Violae, it is remarkable to act on swift and violent effect.
The present invention is made by the following weight proportion raw material: Herba Taraxaci 3-14 part, Radix Isatidis 4-12 part, Fructus Forsythiae 2-10 part, Herba Violae 2-4 part, Radix Scutellariae 1-3 part.
The specific embodiment
The present invention can be prepared into tablet, mixture, injection, wherein with injection treatment directly, rapidly, should deposit.
In order accurately to hold using method and consumption, once did following experiment:
Experimental result shows that using method and dosage have substantial connection, and newborn basic cave injection or ring-like sealing are rapider than intramuscular injection effect, and dosage is also little, and it is excessive harmful on the contrary that consumption is annotated in the cave, increases pain, local swelling.In a word, the intramuscular injection consumption is big, and consumption is little ineffective.For the acute or subacute comprehensive measure that is suitable for, in conjunction with external application, be coated with and put, control development on the skin.To recessive type intramuscular injection every day twice, each 20-30ml, 3-5 days continuously, or dipping, can control development effectively.
Best usage and dosage is intramuscular injection: once measure milch cow 30-40ml, pig, sheep 10-20ml, every day twice, logotype 2-3 days.Or strengthen quick curative effect, and this medicinal liquid can be injected in the Ru Chi lesion by newborn hole, held the nipple repeated massage 3 minutes, each newborn pond 15-20ml, once-a-day, logotype 2-3 days.Cooperate the dipping effect better: after having squeezed milk sooner or later, with this medicinal liquid obliterating nipple, once to measure 10ml, logotype 2-3 days.
One of innovative point of the present invention is the active anti-inflammatory substance that extracts from natural plant, make be used for milch cow lactation period acute, subacute mastitis is more suitable, and is and more economical and more practical than antibiotics, it is about about in the of 30 yuan to cure 1 cattle.
Two of innovative point of the present invention is that intramuscular injection is poured into newborn hole, the dipping external application combines.Single intramuscular injection effect is annotated not as newborn basic cave and is obviously improved in conjunction with newborn hole perfusion effect, if again with the dipping external application or to smear anti-inflammatory ointment just even more ideal.
Three of innovative point of the present invention is plurality of Chinese drug effect synergism.Mastitis, mastitis many because of staphylococcus, haemolysis coccus institute extremely, leading common dandelion always is used for acute mastitis among the present invention, Huang is swollen, cards such as lactiferous ducts obstruction or stagnation of QI hypogalactia, root contains multiple triterpene alcohol, Herba Taraxaci element, to staphylococcus aureus, the haemolysis coccus has stronger killing action, and congested inflammation is had the antipyretic analgesic effect.Collaborative further strengthened hand in hand with Radix Isatidis, Fructus Forsythiae, Radix Scutellariae, Herba Violae etc., it is remarkable to act on swift and violent effect.
Four of innovative point of the present invention is that it is a pure Chinese medicinal preparation, does not contain any antibiotic, chemical medicine, hormone etc., noresidue, has no side effect, and is the environmental type preparation.
Five of innovative point of the present invention is that this product can prevent the recessive type mastitis, and the prevention pathogen is invaded breast, also can be killed very soon even invade.Though latent mammitis breast and milk do not have macroscopic unusual, the sickness rate height influences milk yield and newborn quality, jeopardizes health, and transfers clinical type easily to, so should attach great importance to.Carrying out the nipple dipping with gold breast peace injection, is control latent mammitis efficient ways, can reach and prevent trouble before it happens.

Claims (1)

1. medicine for the treatment of Mammitis of cattle, it is characterized in that its component is Herba Taraxaci, Radix Isatidis, Fructus Forsythiae, Herba Violae, Radix Scutellariae, and its described its composition weight proportioning is Herba Taraxaci 3-14 part, Radix Isatidis 4-12 part, Fructus Forsythiae 2-10 part, Herba Violae 2-4 part, Radix Scutellariae 1-3 part.
CN 02145905 2002-10-22 2002-10-22 Medicine for treating cow mammitis Expired - Fee Related CN1215857C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02145905 CN1215857C (en) 2002-10-22 2002-10-22 Medicine for treating cow mammitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02145905 CN1215857C (en) 2002-10-22 2002-10-22 Medicine for treating cow mammitis

Publications (2)

Publication Number Publication Date
CN1491675A CN1491675A (en) 2004-04-28
CN1215857C true CN1215857C (en) 2005-08-24

Family

ID=34232538

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02145905 Expired - Fee Related CN1215857C (en) 2002-10-22 2002-10-22 Medicine for treating cow mammitis

Country Status (1)

Country Link
CN (1) CN1215857C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1317000C (en) * 2004-12-21 2007-05-23 江苏省农业科学院 Film coating agent for treating mastitis of milch cows and preparation methde
CN100471510C (en) * 2004-12-29 2009-03-25 李发明 Combination of lmedication for treatig mastitis of cow and preparation method
CN101322779B (en) * 2007-06-14 2011-07-20 北京大北农动物保健科技有限责任公司 Chinese medicine for treating mammitis of milk cattle and preparation thereof
CN104161176A (en) * 2013-07-15 2014-11-26 河南联合英伟饲料有限公司 Traditional Chinese medicine feed additive for effectively preventing dairy cow mastitis
CN104288356B (en) * 2014-09-17 2018-05-25 河北科星药业有限公司 Treat traditional Chinese medicine infusion solution of mastitis for milk cows and preparation method thereof

Also Published As

Publication number Publication date
CN1491675A (en) 2004-04-28

Similar Documents

Publication Publication Date Title
Landau et al. Traditional Arab ethno-veterinary practices in small ruminant breeding in Israel
CN104491203A (en) Chinese herbal medicine fermentative extract liquid for preventing and treating cow mastitis and preparation method of Chinese herbal medicine fermentative extract liquid
CN1215857C (en) Medicine for treating cow mammitis
Cui et al. Treatment of the retained placenta in dairy cows: Comparison of a systematic antibiosis with an oral administered herbal powder based on traditional Chinese veterinary medicine
CN112043817A (en) Anti-mite composition and application thereof
CN101972391A (en) Medicinal composition used for treating swine mastitis and preparation method thereof
CN104523897A (en) Enteroclysis medicine composition for treating piglet epidemic diarrhea
Pratama et al. Ethnoveterinary study of medicinal plants used for cattle treatment in Bojonegoro District, East Java, Indonesia
CN100471510C (en) Combination of lmedication for treatig mastitis of cow and preparation method
CN101757136A (en) Traditional Chinese medicine composite for treating viral swine high fever
CN104688808B (en) A kind of Whelk-eliminating paste and preparation method thereof
CN101972451B (en) Compound infusion preparation of Chinese herbal medicines and western medicines for treating cow hysteritis and preparation method thereof
CN1268355C (en) Traditional Chinese medicine for treating cow endo metritis
CN105233184A (en) Disinfectant containing Traditional Chinese medicine ingredients
CN104208194B (en) Traditional Chinese medicine composition for treating bovine endometritis, preparation method and application thereof
CN104784311B (en) Composition of medicine for preventing and treating animal aphtha hoof Huang and preparation method thereof
CN1057468C (en) Chinese medicinal preparation for curing eczematous dermitis of young pigs
CN113876853B (en) Medicine for preventing and treating cow mastitis disease and preparation method and application thereof
CN107582650A (en) A kind of Chinese medicine composition for being used to prevent and treat sow mastitis
US20170266247A1 (en) A novel synergistic herbal formulation for degenerative disease cardiovascular diseases, autoimmune, inflammatory and metabolism disorder and the process of preparing the same
Schlittenlacher Collection of empirical knowledge on the treatment of livestock with medicinal plants and natural substances in Bavaria
CN106581660A (en) Composition for treating microbial infection
CN1981826A (en) Uterus perfusion for treating bull metritis
US20080050456A1 (en) Intramammary formulations
CN1114441C (en) Compound tree peony injecta

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050824

Termination date: 20111022